Katy Eichinger

2.2k total citations
46 papers, 1.1k citations indexed

About

Katy Eichinger is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Katy Eichinger has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cellular and Molecular Neuroscience, 21 papers in Molecular Biology and 15 papers in Neurology. Recurrent topics in Katy Eichinger's work include Genetic Neurodegenerative Diseases (17 papers), Muscle Physiology and Disorders (15 papers) and Neurogenetic and Muscular Disorders Research (12 papers). Katy Eichinger is often cited by papers focused on Genetic Neurodegenerative Diseases (17 papers), Muscle Physiology and Disorders (15 papers) and Neurogenetic and Muscular Disorders Research (12 papers). Katy Eichinger collaborates with scholars based in United States, Australia and United Kingdom. Katy Eichinger's co-authors include Charles A. Thornton, Rabi Tawil, Richard T. Moxley, Chad Heatwole, Krzysztof Sobczak, Masayuki Nakamori, Michael McDermott, Jeffrey Statland, Emma Ciafaloni and William B. Martens and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of Neurology.

In The Last Decade

Katy Eichinger

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katy Eichinger United States 19 806 623 250 241 142 46 1.1k
Nuran Dilek United States 18 398 0.5× 443 0.7× 300 1.2× 178 0.7× 75 0.5× 49 779
Ruth Brassington United Kingdom 10 340 0.4× 161 0.3× 276 1.1× 141 0.6× 58 0.4× 14 740
V. Decostre France 18 894 1.1× 154 0.2× 65 0.3× 148 0.6× 188 1.3× 35 1.2k
Gerardo Nigro Italy 14 517 0.6× 163 0.3× 108 0.4× 132 0.5× 358 2.5× 41 854
Anna Łusakowska Poland 13 376 0.5× 123 0.2× 134 0.5× 324 1.3× 44 0.3× 38 609
Tracey Willis United Kingdom 13 351 0.4× 177 0.3× 60 0.2× 133 0.6× 128 0.9× 47 596
Veeramani Preethish‐Kumar India 17 317 0.4× 100 0.2× 190 0.8× 113 0.5× 97 0.7× 72 652
Kiran Polavarapu India 15 292 0.4× 111 0.2× 178 0.7× 91 0.4× 89 0.6× 85 617
Kristy Rose Australia 15 370 0.5× 112 0.2× 143 0.6× 483 2.0× 39 0.3× 25 837
Johanna C.W. Deenen Netherlands 6 374 0.5× 120 0.2× 117 0.5× 154 0.6× 119 0.8× 12 570

Countries citing papers authored by Katy Eichinger

Since Specialization
Citations

This map shows the geographic impact of Katy Eichinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy Eichinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy Eichinger more than expected).

Fields of papers citing papers by Katy Eichinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katy Eichinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy Eichinger. The network helps show where Katy Eichinger may publish in the future.

Co-authorship network of co-authors of Katy Eichinger

This figure shows the co-authorship network connecting the top 25 collaborators of Katy Eichinger. A scholar is included among the top collaborators of Katy Eichinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katy Eichinger. Katy Eichinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mandarakas, Melissa R., Katy Eichinger, Paula Bray, et al.. (2024). Multicenter Validation of the Charcot-Marie-Tooth Functional Outcome Measure. Neurology. 102(3). e207963–e207963. 4 indexed citations
2.
Dilek, Nuran, Janet E. Sowden, Katy Eichinger, et al.. (2024). Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study. Journal of the Peripheral Nervous System. 29(4). 487–493. 1 indexed citations
3.
Arjomand, Jamshid, Davide Gabellini, Nicol C. Voermans, et al.. (2023). Meeting report: The 2023 FSHD International Research Congress. Neuromuscular Disorders. 35. 53–57. 3 indexed citations
4.
Cornett, Kayla, Sarah P. Garnett, Rosemary Shy, et al.. (2023). Association of Body Mass Index With Disease Progression in Children With Charcot-Marie-Tooth Disease. Neurology. 101(7). e717–e727. 3 indexed citations
5.
Montes, Jacqueline, et al.. (2022). A post pandemic roadmap toward remote assessment for neuromuscular disorders: limitations and opportunities. Orphanet Journal of Rare Diseases. 17(1). 5–5. 14 indexed citations
6.
Duong, Tina, Kristin J. Krosschell, M. James, et al.. (2021). Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases. Frontiers in Genetics. 12. 735936–735936. 4 indexed citations
7.
Grasl, Stefan, Stefan Janik, Gudrun Gröppel, et al.. (2021). Management and outcome of vagus nerve stimulator implantation: experience of an otolaryngeal/neuropediatric cooperation. European Archives of Oto-Rhino-Laryngology. 278(10). 3891–3899. 5 indexed citations
8.
Wang, Leo H., Dennis Shaw, Anna Faino, et al.. (2021). Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy. BMC Musculoskeletal Disorders. 22(1). 262–262. 24 indexed citations
9.
Dobson, Fiona, Ian Woodcock, Kate Carroll, et al.. (2021). Reliability and validity of the FSHD-composite outcome measure in childhood facioscapulohumeral dystrophy. Neuromuscular Disorders. 31(8). 706–715. 7 indexed citations
10.
Bray, Paula, Kayla Cornett, Davide Pareyson, et al.. (2020). Reliability of the Charcot‐Marie‐Tooth functional outcome measure. Journal of the Peripheral Nervous System. 25(3). 288–291. 9 indexed citations
11.
Cornett, Kayla, Manoj P. Menezes, Paula Bray, et al.. (2020). Refining clinical trial inclusion criteria to optimize the standardized response mean of the CMTPedS. Annals of Clinical and Translational Neurology. 7(9). 1713–1715. 15 indexed citations
12.
Sowden, Janet E., et al.. (2019). Measuring peripheral nerve involvement in Friedreich’s ataxia. Annals of Clinical and Translational Neurology. 6(9). 1718–1727. 11 indexed citations
13.
Conway, Kristin M., et al.. (2019). Needs management in families affected by childhood-onset dystrophinopathies. SHILAP Revista de lepidopterología. 7. 2106906470–2106906470. 2 indexed citations
14.
Veerapandiyan, Aravindhan, et al.. (2019). Intrathecal nusinersen in older children and adults with spinal muscular atrophy (S5.001). Neurology. 92(15_supplement). 2 indexed citations
15.
LoRusso, Samantha, Nicholas E. Johnson, Michael McDermott, et al.. (2019). Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study. BMC Neurology. 19(1). 224–224. 32 indexed citations
16.
Veerapandiyan, Aravindhan, Katy Eichinger, Érin Collins, et al.. (2018). Cervical Puncture to Deliver Nusinersen in Patients with Spinal Muscular Atrophy and no Lumbar Access (P2.333). Neurology. 90(15_supplement). 2 indexed citations
17.
18.
Wagner, Stacey D., Adam J. Struck, Dylan R. Farnsworth, et al.. (2016). Dose-Dependent Regulation of Alternative Splicing by MBNL Proteins Reveals Biomarkers for Myotonic Dystrophy. PLoS Genetics. 12(9). e1006316–e1006316. 73 indexed citations
19.
Eichinger, Katy, Chad Heatwole, Carla Grosmann, et al.. (2016). Validity of the 6 minute walk test in facioscapulohumeral muscular dystrophy. Muscle & Nerve. 55(3). 333–337. 33 indexed citations
20.
Heatwole, Chad, Katy Eichinger, Deborah I. Friedman, et al.. (2010). Open-Label Trial of Recombinant Human Insulin-like Growth Factor 1/Recombinant Human Insulin-like Growth Factor Binding Protein 3 in Myotonic Dystrophy Type 1. Archives of Neurology. 68(1). 37–44. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nuran Dilek Breakdown of academic impact, for papers by Ruth Brassington Breakdown of academic impact, for papers by V. Decostre Breakdown of academic impact, for papers by Gerardo Nigro Breakdown of academic impact, for papers by Anna Łusakowska Breakdown of academic impact, for papers by Tracey Willis Breakdown of academic impact, for papers by Veeramani Preethish‐Kumar Breakdown of academic impact, for papers by Kiran Polavarapu Breakdown of academic impact, for papers by Kristy Rose Breakdown of academic impact, for papers by Johanna C.W. Deenen
Rankless by CCL
2026